Biogen says low dose of its experimental tau-reducing drug fares even better after nearly 2 years
BOSTON — The benefits of Biogen’s experimental Alzheimer’s drug seem to get better with time. Over the summer, Biogen reported that the lowest dose of its …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Source link







